- Home
- MRTN vs EWTX Comparison
MRTN vs EWTX Comparison
Compare MRTN & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRTN
- EWTX
- Stock Information
- Founded
- MRTN 1946
- EWTX 2017
- Country
- MRTN United States
- EWTX United States
- Employees
- MRTN N/A
- EWTX N/A
- Industry
- MRTN Trucking Freight/Courier Services
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- MRTN Industrials
- EWTX Health Care
- Exchange
- MRTN Nasdaq
- EWTX Nasdaq
- Market Cap
- MRTN 1.1B
- EWTX 1.2B
- IPO Year
- MRTN 1986
- EWTX 2021
- Fundamental
- Price
- MRTN $12.99
- EWTX $13.35
- Analyst Decision
- MRTN Buy
- EWTX Buy
- Analyst Count
- MRTN 2
- EWTX 9
- Target Price
- MRTN $19.00
- EWTX $39.89
- AVG Volume (30 Days)
- MRTN 458.5K
- EWTX 983.7K
- Earning Date
- MRTN 07-17-2025
- EWTX 08-07-2025
- Dividend Yield
- MRTN 1.85%
- EWTX N/A
- EPS Growth
- MRTN N/A
- EWTX N/A
- EPS
- MRTN 0.26
- EWTX N/A
- Revenue
- MRTN $937,188,000.00
- EWTX N/A
- Revenue This Year
- MRTN N/A
- EWTX N/A
- Revenue Next Year
- MRTN $7.13
- EWTX N/A
- P/E Ratio
- MRTN $49.84
- EWTX N/A
- Revenue Growth
- MRTN N/A
- EWTX N/A
- 52 Week Low
- MRTN $12.52
- EWTX $10.60
- 52 Week High
- MRTN $19.26
- EWTX $38.12
- Technical
- Relative Strength Index (RSI)
- MRTN 47.46
- EWTX 34.22
- Support Level
- MRTN $12.72
- EWTX $12.15
- Resistance Level
- MRTN $13.07
- EWTX $14.85
- Average True Range (ATR)
- MRTN 0.31
- EWTX 0.68
- MACD
- MRTN -0.01
- EWTX -0.16
- Stochastic Oscillator
- MRTN 30.00
- EWTX 23.13
About MRTN Marten Transport Ltd.
Marten Transport Ltd is a temperature-sensitive truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. It operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.